Atlas Trials

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Clinical trial NCT07633470 · RECRUITING

Trial details

NCT number
NCT07633470
Sponsor
Alpha Cognition, Inc
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2026-05-20
Primary completion
2027-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.